Ciaramella Giuseppe 4

What Happened
Giuseppe Ciaramella, President of Beam Therapeutics, was granted 40,000 restricted stock units (RSUs) on March 31, 2026. The Form 4 reports the acquisition price as $0.00 (an award/grant), so no cash purchase occurred. Each RSU represents the contingent right to one share of BEAM common stock; the award will convert to shares as it vests.

Key Details

• Transaction date: 2026-03-31; transaction type: Award/Grant (code A).
• Units granted: 40,000 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: RSUs vest in four substantially equal installments on each of the first four anniversaries of the grant date, subject to continued service (see F1).
• Filing status: Form filed 2026-04-02; no late filing indicated in the report.

Context
RSU grants are a common form of executive compensation and vest over time, aligning management with shareholder interests as shares are delivered at vesting. Because this was an award (not an open-market purchase or sale), it does not represent an immediate cash investment or liquidation by the insider.